References
- Cahalan S. Brain on Fire: My Month of Madness. New York: Simon & Schuster; 2012.
- Carr D. Turning a zebra into a horse. Presented at: Social Media and Critical Care Conference, March 2019; Sydney, Australia.
- Jammoul A, Li Y, Rae-Grant A. Autoantibody-mediated encephalitis: not just paraneoplastic, not just limbic, and not untreatable. Cleve Clin J Med. 2016;83(1):43-53.
- Binks SNM, Klein CJ, Waters P, et al. LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes. J Neurol Neurosurg Psychiatry. 2018;89(5):526-534.
- Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391-404.
- Dubey D, Pittock SJ, Kelly CR, et al. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol. 2018;83(1):166-177.
Explore This Issue
ACEP Now: Vol 38 – No 06 – June 2019Pages: 1 2 | Single Page
2 Responses to “Demonic Possession or Autoantibody-Mediated Encephalitis?”
May 25, 2020
JuliaFascinating. Could seemingly demonic possession be attributed to any subtype of encephalitis or does it generally relate to Seronegative Limbic Encephalitis, Non-Paraneoplastic Limbic Encephalitis, and Typical/Atypical Limbic Encephalitis?
May 28, 2020
Ryan RadeckiTo my knowledge, it pertains specifically to these NMDA receptor antibodies – and produces the clinical syndromes associated with other hallucinogenic pharmacology (e.g., Ibotenic acid in Amanita mushrooms).